Abstract
Cytochrome P450 (CYP) 3A4 is of great interest because of its important roles in the oxidation of numerous drugs and xenobiotics. HDJ-1, a molecular chaperone in human, is known to assist the correct folding of unfolded proteins. To achieve a high yield of recombinant human CYP3A4 inEscherichia coli, the CYP3A4 encoding gene was co-expressed with the chaperone HDJ-1, under the control of an inducibletac promoter in a bicistronic format. The levels of expression of the CYP3A4 in the bicistronic construct reached up to 715 nmol (liter culture)-1 within 16 h at 37°C, which was about a 3.3-fold increase compared to that of the CYP3A4 alone without the HDJ-1. By co-expression with HDJ-1, the catalytic activity of CYP3A4 was also increased by ~15-fold. The amount of activity increase was similar to that of the CYP production at the whole cell level. The present over-expression system may be useful for the rapid production of large amounts of active CYP3A4 inE. coli.
Similar content being viewed by others
References
Arlotto, M. P., Trant, J. M., and Estabrook, R. W., Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function.Methods Enzymol., 206, 454–462 (1991).
Bao, Y. P., Cook, L. J., ODonovan, D., Uyama, E., and Rubinsztein, D. C., Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy.J. Biol. Chem., 277, 12263–12269 (2002).
Distlerath, L. M., Reilly, P. E., Martin, M. V., Davis, G. G., Wilkinson, G. R., and Guengerich, F. P., Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetinO- deethylation, two prototypes for genetic polymorphism in oxidative drug metabolism.J. Biol. Chem., 260, 9057–9067 (1985).
Freeman, B. C. and Morimoto, R. I., The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.EMBO J., 15, 2969–2979 (1996).
Gillam, E. M., Baba, T., Kim, B. R., Ohmori, S., and Guengerich, F. P. Expression of modified human cytochrome P450 3A4 inEscherichia coli and purification and reconstitution of the enzyme.Arch. Biochem. Biophys., 305, 123–131 (1993).
Guengerich, F. P. and Parikh, A., Expression of drug-metabo-lizing enzymes.Curr. Opin. Biotechnol., 8, 623–628 (1997).
Guengerich, F. P., Human cytochrome P450 enzymes. In Oritiz de Montelano, P. R. (Ed.) Cytochrome P450, 2nd ed. Plenum Press, New York, pp. 473–535 (1995).
Hanna, I. H., Teiber, J. F., Kokones, K. L., and Hollenberg, P. F., Role of the alanine at position 363 of cytochrome P450 2B2 in influencing the NADPH- and hydroperoxide-supported activities.Arch. Biochem. Biophys., 350, 324–332 (1998).
Inoue, E., Takahashi, Y., Imai, Y., and Kamataki, T., Development of bacterial expression system with high yield of CYP3A7, a human fetus-specific form of cytochrome P450.Biochem. Biophys. Res. Commun., 269, 623–627 (2000).
Iwata, H., Fujita, K-l., Kushida, H., Suzuki, A., Konno, Y., Nakamura, K., Fujino, A., and Kamataki, T., High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase inEscherichia coli.Biochem. Pharmacol., 55, 1315–1325 (1998).
Nagata, H., Hansen, W. J., Freeman, B., and Welch, W. J., Mammalian cytosolic DnaJ homologues affect the hsp70 chaperone-substrate reaction cycle, but do not interact directly with nascent or newly synthesized proteins.Biochemistry, 37, 6924–6938 (1998).
Omura, T. and Sato, R., The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature.J. Biol. Chem., 239, 2370–2378 (1964).
Parikh, A. and Guengerich, F P., Expression, purification, and characterization of a catalytically active human cytochrome P450 3A4: Rat NADPH-cytochrome P450 fusion protein.Protein Expr. Purif., 9, 346–354 (1997).
Pritchard, M. P., Ossentian, R., Li, D. N., Henderson, C. J., Burchell, B., Wolf, R., and Friedberg, T., A general strategy for the expression of recombinant human cytochrome P450s inEscherichia coli using bacterial signal peptides: Ex-pression of CYP3A4, CYP2A6, and CYP2E1.Arch. Biochem. Biophys., 345, 342–354 (1997).
Sandhu, P., Baba, T., and Guengerich, F. P., Expression of modified cytochrome P450 2C10 (2C9) inEscherichia coli, purification, and reconstitution of catalytic activity.Arch. Biochem. Biophys., 306, 443–450 (1993).
Sanger, F., Coulson, A. R., Barrell, B. G., Smith, A. J., and Roe, B. A., Cloning in single-stranded bacteriophage as an aid to rapid DNA sequencing.J. Mol. Biol., 143, 161–178 (1980).
Tang, W. and Stearns, R. A., Heterotopic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.Curr. Drug Metab., 2, 185–198 (2001).
Wrighton, S.A. and Stevens, J.C., The humanhepatic cytochromes P450 involved in drug metabolism.Crit. Rev. Toxcol., 22, 1–21 (1992).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Ahn, T., Yun, CH. High-level expression of human cytochrome P450 3A4 by co-expression with Human molecular chaperone HDJ-1 (Hsp40). Arch Pharm Res 27, 319–323 (2004). https://doi.org/10.1007/BF02980067
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02980067